BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9247597)

  • 1. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
    Miyatake S; Sakuma M; Saito T
    Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
    J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
    Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
    Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
    Lee IH; Li WP; Hisert KB; Ivashkiv LB
    J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
    Thomis DC; Lee W; Berg LJ
    J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site.
    Karras JG; Wang Z; Coniglio SJ; Frank DA; Rothstein TL
    J Immunol; 1996 Jul; 157(1):39-47. PubMed ID: 8683142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.
    Wang KS; Ritz J; Frank DA
    J Immunol; 1999 Jan; 162(1):299-304. PubMed ID: 9886399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of STAT5 activation influences the response of interleukin-2 receptor alpha gene to different cytokines.
    Imbert V; Renauld PR
    Eur Cytokine Netw; 1999 Mar; 10(1):71-8. PubMed ID: 10210776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
    Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
    Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus.
    Avota E; Avots A; Niewiesk S; Kane LP; Bommhardt U; ter Meulen V; Schneider-Schaulies S
    Nat Med; 2001 Jun; 7(6):725-31. PubMed ID: 11385511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
    Moon JJ; Nelson BH
    J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
    Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.